Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema
Abstract Patients with complicated parapneumonic effusion (CPPE)/empyema have high morbidity and mortality, particularly when adequate management is delayed. We aimed to investigate novel dysregulated cytokines that can be used as biomarkers for infectious pleural effusions, especially for CPPE/empy...
Guardado en:
Autores principales: | Chia-Yu Yang, Yu-Hsuan Kuo, Min Chen, Chih-Liang Wang, Li-Jane Shih, Yu-Ching Liu, Pei-Chun Hsueh, Yi-Hsuan Lai, Chi-Ming Chu, Chih-Ching Wu, Kuo-An Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9b16fafe185748a186e52c895be8b650 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Proteome profiling reveals novel biomarkers to identify complicated parapneumonic effusions
por: Kuo-An Wu, et al.
Publicado: (2017) -
Potential diagnostic value of pleural fluid cytokines levels for tuberculous pleural effusion
por: Neda Dalil Roofchayee, et al.
Publicado: (2021) -
COMPLEX TREATMENT OF ACUTE NONSPECIFIC PLEURAL EMPYEMA
por: I. V. Nikolaychuk, et al.
Publicado: (2012) -
Pleural empyema in children – benefits of primary thoracoscopic treatment
por: Roksana Barglik, et al.
Publicado: (2020) -
FUNDAMENTAL IMMUNOBIOLOGY OF PRO-INFLAMMATORY CYTOKINES AND MIF
por: A. P. Suslov, et al.
Publicado: (2014)